DIUCARDIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diucardin, and when can generic versions of Diucardin launch?
Diucardin is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in DIUCARDIN is hydroflumethiazide. There is one drug master file entry for this compound. Additional details are available on the hydroflumethiazide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIUCARDIN?
- What are the global sales for DIUCARDIN?
- What is Average Wholesale Price for DIUCARDIN?
Summary for DIUCARDIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Patent Applications: | 4,195 |
| DailyMed Link: | DIUCARDIN at DailyMed |
US Patents and Regulatory Information for DIUCARDIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | DIUCARDIN | hydroflumethiazide | TABLET;ORAL | 083383-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
